Followers | 7 |
Posts | 1577 |
Boards Moderated | 0 |
Alias Born | 02/27/2014 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, December 16, 2014 3:05:10 PM
Despite continuous dilution by management in the past, I see no particular interest from the management and board to continue down that path in 2015. Those in power need the share price to appreciate.
There are enough important endorsements at these stage to support up to $2 billion in sales. I mean, Musclepharm invested in Arnold Schwarzenegger, Tiger Woods and Johnny Manziel....pretty heavy names.
Musclepharm is getting quite so important to contract manufacturers giving it some leverage in terms of pricing pressure and interesting alliances.
I'm sure Musclepharm will improve branding efforts and revamp the Fitmiss project.
Musclepharm seems to be a fair bet at this price...the current price level and price drop more or less dictates what the shareholders' letter will tell us.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM